Comments
Dr Reddy’s Laboratories announced today that it has launched Moxifloxacin Hydrochloride Tablets 400 mg, a therapeutic equivalent generic version of Avelox® (moxifloxacin HCl) tablets 400 mg in the US market. It is an anti-bacterial that is useful for adults in treating acute bacterial sinusitis, bronchitis, skin and abdominal infections.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.